RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
MegaPro Biomedical Co Stock

MegaPro Biomedical Co ROA 2024

MegaPro Biomedical Co ROA

-0.33

Ticker

6827.TWO

ISIN

TW0006827009

In 2024, MegaPro Biomedical Co's return on assets (ROA) was -0.33, a 58.21% increase from the -0.21 ROA in the previous year.

MegaPro Biomedical Co Aktienanalyse

What does MegaPro Biomedical Co do?

MegaPro Biomedical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding MegaPro Biomedical Co's Return on Assets (ROA)

MegaPro Biomedical Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing MegaPro Biomedical Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider MegaPro Biomedical Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in MegaPro Biomedical Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about MegaPro Biomedical Co stock

What is the Return on Assets (ROA) of MegaPro Biomedical Co this year?

The Return on Assets (ROA) of MegaPro Biomedical Co is -0.33 undefined this year.

What was the ROA of MegaPro Biomedical Co compared to the previous year?

The ROA of MegaPro Biomedical Co has increased by 58.21% compared to the previous year.

What consequences do high ROA have for investors of MegaPro Biomedical Co?

A high ROA is advantageous for investors of MegaPro Biomedical Co, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in MegaPro Biomedical Co?

A low ROA can be unfavorable for investors of MegaPro Biomedical Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of MegaPro Biomedical Co affect the company?

An increase in ROA of MegaPro Biomedical Co can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of MegaPro Biomedical Co impact the company?

A reduction in the ROA of MegaPro Biomedical Co can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of MegaPro Biomedical Co?

Some factors that can influence the ROA of MegaPro Biomedical Co include revenue, operating costs, asset structure, and industry average.

Why is the ROA of MegaPro Biomedical Co important for investors?

The ROA of MegaPro Biomedical Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can MegaPro Biomedical Co take to improve ROA?

To improve ROA, MegaPro Biomedical Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does MegaPro Biomedical Co pay?

Over the past 12 months, MegaPro Biomedical Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MegaPro Biomedical Co is expected to pay a dividend of 0 TWD.

What is the dividend yield of MegaPro Biomedical Co?

The current dividend yield of MegaPro Biomedical Co is .

When does MegaPro Biomedical Co pay dividends?

MegaPro Biomedical Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of MegaPro Biomedical Co?

MegaPro Biomedical Co paid dividends every year for the past 0 years.

What is the dividend of MegaPro Biomedical Co?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is MegaPro Biomedical Co located?

MegaPro Biomedical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von MegaPro Biomedical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of MegaPro Biomedical Co from 9/29/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did MegaPro Biomedical Co pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of MegaPro Biomedical Co in the year 2023?

In the year 2023, MegaPro Biomedical Co distributed 0 TWD as dividends.

In which currency does MegaPro Biomedical Co pay out the dividend?

The dividends of MegaPro Biomedical Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von MegaPro Biomedical Co

Our stock analysis for MegaPro Biomedical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MegaPro Biomedical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.